# Ernexa Therapeutics Inc.: Form 8-K, filed Feb 29, 2016

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2016-02-29
- Accepted by EDGAR: Feb 29, 2016, 16:41 ET
- Period: 2016-02-24
- Accession: 0001493152-16-007725
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000149315216007725/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000149315216007725/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000149315216007725/form8-k.htm

Filed Feb 29, 2016.
Source: SEC EDGAR, the filing index for accession 0001493152-16-007725. Last ingested by Listed: Nov 6, 2026, 17:52 ET. No prices; not investment advice.